Literature DB >> 30250984

The World of Melanoma: Epidemiologic, Genetic, and Anatomic Differences of Melanoma Across the Globe.

Florentia Dimitriou1, Regina Krattinger1, Egle Ramelyte1, Marjam J Barysch1, Sara Micaletto1, Reinhard Dummer1, Simone M Goldinger2.   

Abstract

PURPOSE OF REVIEW: As cancer remains an increasing problem in industrial countries, the incidence of melanoma has risen rapidly in many populations during the last decades and still continues to rise. Current strategies aiming to control the disease have largely focused on improving the understanding of the interplay of causal factors for this cancer. RECENT
FINDINGS: Cutaneous melanoma shows clear differences in incidence, mortality, genomic profile, and anatomic presentation, depending on the country of residence, ethnicity, and socioeconomic status. Known risk factors are multiple atypical nevi, positive family and/or personal history, immune suppressive diseases or treatments, and fair skin phenotype. Besides new adjuvant therapeutic options, changed attitude toward leisure and sun exposure, primary prevention, and early detection are major contributors to disease control. Melanoma is a disease of multifactorial causality and heterogeneous presentation. Its subtypes differ in origin, anatomical site, role of UV radiation, and mutational profile. Better understanding of these differences may improve prevention strategies and therapeutic developments.

Entities:  

Keywords:  Epidemiology; Ethnicity; Immunotherapy; Melanoma; Melanoma genetics; Targeted therapy

Mesh:

Year:  2018        PMID: 30250984     DOI: 10.1007/s11912-018-0732-8

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  79 in total

Review 1.  Melanoma risk in congenital melanocytic naevi: a systematic review.

Authors:  S Krengel; A Hauschild; T Schäfer
Journal:  Br J Dermatol       Date:  2006-07       Impact factor: 9.302

Review 2.  Prevention and early detection strategies for melanoma and skin cancer. Current status.

Authors:  H K Koh; A C Geller; D R Miller; T A Grossbart; R A Lew
Journal:  Arch Dermatol       Date:  1996-04

3.  BRAF inhibitor activity in V600R metastatic melanoma--response.

Authors:  Oliver Klein; Arthur Clements; Alexander M Menzies; Sandra O'Toole; Richard F Kefford; Georgina V Long
Journal:  Eur J Cancer       Date:  2013-03-13       Impact factor: 9.162

Review 4.  Risk of subsequent cutaneous malignancy in patients with prior melanoma: a systematic review and meta-analysis.

Authors:  R J T van der Leest; S C Flohil; L R Arends; E de Vries; T Nijsten
Journal:  J Eur Acad Dermatol Venereol       Date:  2014-12-10       Impact factor: 6.166

5.  Melanoma epidemic: an analysis of six decades of data from the Connecticut Tumor Registry.

Authors:  Alan C Geller; Richard W Clapp; Arthur J Sober; Lou Gonsalves; Lloyd Mueller; Cindy L Christiansen; Waqas Shaikh; Donald R Miller
Journal:  J Clin Oncol       Date:  2013-09-16       Impact factor: 44.544

6.  Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.

Authors:  J Ferlay; E Steliarova-Foucher; J Lortet-Tieulent; S Rosso; J W W Coebergh; H Comber; D Forman; F Bray
Journal:  Eur J Cancer       Date:  2013-02-26       Impact factor: 9.162

7.  Cutaneous melanomas associated with nevi.

Authors:  Caroline Bevona; William Goggins; Timothy Quinn; Julie Fullerton; Hensin Tsao
Journal:  Arch Dermatol       Date:  2003-12

8.  Sex is an independent prognostic indicator for survival and relapse/progression-free survival in metastasized stage III to IV melanoma: a pooled analysis of five European organisation for research and treatment of cancer randomized controlled trials.

Authors:  Arjen Joosse; Sandra Collette; Stefan Suciu; Tamar Nijsten; Poulam M Patel; Ulrich Keilholz; Alexander M M Eggermont; Jan Willem W Coebergh; Esther de Vries
Journal:  J Clin Oncol       Date:  2013-05-20       Impact factor: 44.544

9.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

10.  Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas.

Authors:  Michael Krauthammer; Yong Kong; Antonella Bacchiocchi; Perry Evans; Natapol Pornputtapong; Cen Wu; Jamie P. McCusker; Shuangge Ma; Elaine Cheng; Robert Straub; Merdan Serin; Marcus Bosenberg; Stephan Ariyan; Deepak Narayan; Mario Sznol; Harriet M Kluger; Shrikant Mane; Joseph Schlessinger; Richard P Lifton; Ruth Halaban
Journal:  Nat Genet       Date:  2015-07-27       Impact factor: 41.307

View more
  37 in total

1.  Do Thiazide Diuretics Increase the Risk of Skin Cancer? A Critical Review of the Scientific Evidence and Updated Meta-Analysis.

Authors:  Benedetta Bendinelli; Giovanna Masala; Giuseppe Garamella; Domenico Palli; Saverio Caini
Journal:  Curr Cardiol Rep       Date:  2019-07-27       Impact factor: 2.931

Review 2.  Cancer and Sleep Apnea: Cutaneous Melanoma as a Case Study.

Authors:  Miguel Angel Martinez-Garcia; Francisco Campos-Rodriguez; Isaac Almendros; Francisco Garcia-Rio; Manuel Sanchez-de-la-Torre; Ramon Farre; David Gozal
Journal:  Am J Respir Crit Care Med       Date:  2019-12-01       Impact factor: 21.405

3.  LncRNA HOXA11-AS regulates the proliferation and epithelial to mesenchymal transition of human skin cancer cells.

Authors:  Jigang Wang; Xiuli Li; Hui Li; Xin Li
Journal:  3 Biotech       Date:  2021-01-02       Impact factor: 2.406

4.  The role of FoxP3+ regulatory T cells and IDO+ immune and tumor cells in malignant melanoma - an immunohistochemical study.

Authors:  Satu Salmi; Anton Lin; Benjamin Hirschovits-Gerz; Mari Valkonen; Niina Aaltonen; Reijo Sironen; Hanna Siiskonen; Sanna Pasonen-Seppänen
Journal:  BMC Cancer       Date:  2021-05-29       Impact factor: 4.430

5.  An Ecological Study Indicates the Importance of Ultraviolet A Protection in Sunscreens.

Authors:  Samar Merhi; Pascale Salameh; Peter Kaplan; Shayak Banerjee; Mohamed Lajnef; Emmanuel L P Dumont; Khaled Ezzedine
Journal:  Acta Derm Venereol       Date:  2021-06-28       Impact factor: 3.875

Review 6.  Immunotherapy in the Treatment of Metastatic Melanoma: Current Knowledge and Future Directions.

Authors:  Massimo Ralli; Andrea Botticelli; Irene Claudia Visconti; Diletta Angeletti; Marco Fiore; Paolo Marchetti; Alessandro Lambiase; Marco de Vincentiis; Antonio Greco
Journal:  J Immunol Res       Date:  2020-06-28       Impact factor: 4.818

7.  Impact of general anaesthesia in overall and disease-free survival compared to other types of anaesthesia in patients undergoing surgery for cutaneous melanoma: a systematic review and meta-analysis protocol.

Authors:  Bruno Luís de Castro Araujo; Jadivan Leite de Oliveira; Flavia de Miranda Corrêa; Luis Eduardo Santos Fontes; Andreia Cristina de Melo; Luiz Claudio Santos Thuler
Journal:  BMJ Open       Date:  2019-07-27       Impact factor: 2.692

8.  In vitro selective cytotoxicity of the dietary chalcone cardamonin (CD) on melanoma compared to healthy cells is mediated by apoptosis.

Authors:  Lena Berning; Lisa Scharf; Elif Aplak; David Stucki; Claudia von Montfort; Andreas S Reichert; Wilhelm Stahl; Peter Brenneisen
Journal:  PLoS One       Date:  2019-09-25       Impact factor: 3.240

9.  Malignancy Rate of Indeterminate Findings on FDG-PET/CT in Cutaneous Melanoma Patients.

Authors:  Ken Kudura; Florentia Dimitriou; Daniela Mihic-Probst; Urs J Muehlematter; Tim Kutzker; Lucas Basler; Robert Förster; Reinhard Dummer; Joanna Mangana; Lars Husmann; Irene A Burger; Michael Christoph Kreissl
Journal:  Diagnostics (Basel)       Date:  2021-05-15

10.  Food and Beverage Consumption and Melanoma Risk: A Population-Based Case-Control Study in Northern Italy.

Authors:  Carlotta Malagoli; Marcella Malavolti; Francesca Farnetani; Caterina Longo; Tommaso Filippini; Giovanni Pellacani; Marco Vinceti
Journal:  Nutrients       Date:  2019-09-12       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.